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Abstract
Background: Colorectal cancer (CRC) is the third most common cancer in the world. The current available treatments
for CRC include surgery, chemotherapy and radiotherapy. However, surgery is only useful when the disease is
diagnosed at the earlier stage. Chemotherapy and radiotherapy are associated with numerous side effects that
decrease the patients’ quality of life. Safer, effective alternatives, such as natural compounds, to chemotherapy
are desirable. This study assessed the efficacy of free fatty acid (FFA) extract of krill oil on three human CRC
cells lines.
Methods: HCT-15, SW-480 and Caco-2 cells were treated with the FFA extracts of krill oil and fish oil for 48 h
while treatments with the bioactive omega-3 polyunsaturated fatty acids (LC n-3 PUFA) of these marine oils,
eicosapentaenoic acid (EPA, C20:5n-3) and docosahexaenoic acid (DHA, C22:6n-3) in comparison with a n-6
PUFA, arachnoid acid (AA, C20:4n-6) were up to 72 h at the concentrations of 50, 100, 150 and 200 μM. Effects
of all the treatments on cell proliferation were assessed using a water-soluble tetrazolium-1 (WST-1) assay kit at
24, 48 and 72 h. Effects of FFA extract of krill oil and EPA on apoptosis and mitochondrial membrane potential
were determined using commercial kits after 48 h of treatment.
Results: Krill oil extract inhibited cell proliferation of all three cell lines in the similar manner as fish oil extract.
A significant cell apoptosis and increase in mitochondrial membrane potential were observed after the treatment with
krill oil extract. EPA at the concentration of 200 μM reduced significantly the proliferation of HCT-15 and SW-480 at 24,
48 and 72 h. In addition, EPA treatment (100 and 200 μM) resulted in significant cell apoptosis in all three cell lines. No
significant changes were observed after treatment with DHA and AA.
Conclusions: Our results indicate that the FFA extract of krill oil maybe an effective chemotherapeutic agent to
suppress proliferation and induce apoptosis in CRC cells through its bioactive constitute EPA. Although the exact
mechanism of the pro-apoptotic properties of krill oil extract is unclear, mitochondrial pathway seems to be implicated.
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DHA, Docosahexaenoic acid; DMEM, Dulbecco’s modified eagle’s medium; DMSO, Dimethyl sulfoxide;
DPA, Docosapentaenoic acid; EPA, Eicosapentaenoic acid; FAME, Fatty acids methyl esters; FCS, Foetal calf serum;
FFA, Free Fatty Acids; FID, Flame ionization detector; GC, Gas chromatography; HEPES, 4-2- hydroxyethyl −1-
piperazineethanesulfonic; LC n-3 PUFA, Long chain n-3 PUFA; MMP, Mitochondrial membrane potential;
MRPs, Multidrug resistances-associated proteins; MUFA, Monounsaturated fatty acids; n-6, Omega 6; PBS, Phosphate
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buffered saline; PGE2, Prostaglandin E2; PGE3, Prostaglandin E3; PUFA, Polyunsaturated fatty acids; ROS, Reactive oxygen
species; SD, Standard deviation; SEM, Standard error of mean; SFA, Saturated fatty acids; WST-1, Water soluble
tetrazolium-1
Background
Colorectal cancer (CRC) is the third most common can-
cer in men and women, accounting for approximately
9 % of mortality caused by cancer each year [1, 2]. The
initiation of CRC is a complex and multifactorial process
that is associated with progressive accumulation of gen-
etic and epigenetic alterations, and these transform nor-
mal colonic/rectal mucosa into invasive metastatic
carcinoma [3, 4]. Among many factors associated with
the development of colorectal cancer, more than 70 % of
CRC patients diagnosed are sporadic, and environmental
factors have been the main cause for the majority of in-
cidence [3]. Diet is one of the main environmental fac-
tors, with 90 % of the CRC reported to be associated
with high intake of saturated fat, red meat, n-6 polyun-
saturated fatty acids (PUFA), and low intake of fibres
and vitamins [5].
The current available treatments for CRC include sur-
gery, chemotherapy and radiotherapy [3, 6]. However,
surgery is only curative when the disease is diagnosed at
an earlier stage. Chemotherapy and radiotherapy are as-
sociated with numerous side effects, such as myelosup-
pression, mucositis, dermatitis and diarrhoea, thus these
treatments have a significant impact on patient's quality
of life [6, 7]. In recent years, the potential role of nutri-
ents as preventive/therapeutic agents has been one of
the main foci in cancer research [6–8].
Fish oil is a rich source of long chain omega-3 polyun-
saturated fatty acids (LC n-3 PUFA), mainly eicosapenta-
enoic acid (EPA, C20:5n-3) and docosahexaenoic acid
(DHA, C22:6n-3). EPA and DHA have demonstrated
preventive and therapeutic effects on the CRC [9, 10].
Epidemiological studies showed that increased consump-
tion of fish oil or LC n-3 PUFA is inversely correlated
with CRC incidence [11, 12]. Studies have shown that
LC n-3 PUFA have growth-inhibitory and pro-apoptotic
effects on colon cancer cells such as HT-29, HCT-116,
SW-480 and Caco-2 [13–15]. Animal studies showed
that fish oil supplementation reduced the number and
size of polyps and suppressed the growth of cancer xe-
nografts in nude mice [16–20].
Several sustainable alternatives of fish oil have been
identified to meet the demand for LC n-3 PUFA during
last decades and one of these is the krill oil. Krill oil is
extracted from Euphasia superba, a crustacean species
similar to shrimp found in the Southern Ocean [8].
Apart from the LC n-3 PUFA, EPA and DHA, krill oil
also contains astaxanthin (provitamin E), flavonoids
and vitamin-A. Different from fish oil, in the krill oil,
EPA and DHA are bound to the phospholipids [21, 22];
while in the fish oil they are mainly bound to the tri-
glycerides [23]. Studies have shown that the phospho-
lipids bound n-3 PUFA can penetrate through cell
membrane efficiently [24] than those bound to glycerol
in triglycerides thus could potentially lead to better
health outcomes [8, 25].
Preliminary studies have shown that krill oil has anti-
cancer properties such as inhibition of proliferation of
osteosarcoma and colon cancer SW-480 cells [8, 26].
However, little information is available on the effect of
krill oil on other CRC cells, and no data are available on
its impact on cell apoptosis. Apoptosis is a key process
of programmed cell death, which plays a crucial role in
maintaining cellular homeostasis between cell division
and cell death [27]. Alterations in the mitochondrial
membrane potential (MMP) and permeability could trig-
ger the release of cytochrome c into the cytosol, which
activates caspases that in turn, induce apoptosis [11]. In
the present study, we investigated the effects of free fatty
acid (FFA) extract from krill oil in comparison with that
from fish oil on three human CRC cell lines HCT-15,
SW-480 and Caco-2. In addition, effects of EPA and
DHA on these cells are also assessed. To the best of our
knowledge, this is the first study assessing the impacts of
krill oil on cell apoptosis and investigating whether the
apoptotic process is mediated by changes in MMP.
Methods
Cell lines and culture conditions
The human colon adenocarcinoma cell lines of HCT-
15, SW-480 and Caco-2 were obtained from the
American Tissue Culture Collection (ATCC) Manas-
sas, VA, USA. HCT-15 and SW-480 cell lines were
maintained in RPMI 1640 medium (SAFCO) (Sigma
Aldrich, Castle Hill, NSW) supplemented with foetal
calf serum (FCS, 10 %) (Hyclone Quantum Scientific,
Clayton South, VIC), glutamine (10 mM), 4-2-
hydroxyethyl-1-piperazineethanesulfonic acid (HEPES
10 mM) and penicillin (100U/ml)/streptomycin
(100 μg/ml) (Sigma Aldrich, Castle Hill, NSW). The
Caco-2 cell line was maintained in Dulbecco’s Modified Ea-
gle’s Medium (DMEM) (Sigma Aldrich, Castle Hill, NSW)
supplemented with 20%FCS and penicillin (100U/ml)/
streptomycin (100 μg/ml), 2 mM/L glutamine, 0.1 mM
non-essential amino acids. Cells were grown at 37 °C in
5 % CO2 humidified atmosphere.
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Extraction of free fatty acids from oils and fatty acid
solution preparation
Krill oil and fish oil (Swisse Wellness Pty Ltd., Victoria,
Australia) were purchased from the local Chemist. Free
fatty acids were extracted from krill oil and fish oil fol-
lowing the hydrolysis (saponification) method of Salimon
et al. [28]. The extracts were dissolved in the Dimethyl
Sulfoxide (DMSO) and stored at −20 °C. The final treat-
ment solutions contained 1 % DMSO as solvent. Individ-
ual PUFA including EPA, DHA and Arachnoid Acid
(AA) were purchased from Nu-Chek-Prep, Elysian, USA.
Fatty acid solutions were made up by dissolving the indi-
vidual fatty acid in ethanol. The final treatment solutions
contained < 0.1 % ethanol as solvent.
Cell proliferation assays
A water-soluble tetrazolium-1 (WST-1) assay kit (Roche
Diagnostics GmbH, Germany) was used to determine
the proliferative potential of cancer cells. Cells were
seeded and cultured at 1 × 104 cells per well in 96-well
plates for 24 h, and then treated with individual PUFA
solutions for 24, 48 or 72 h; or free fatty acid extract so-
lutions of oils (krill oil or fish oil) for 48 h. All treat-
ments were performed in quadruplicates. For PUFA
treatments, three concentrations of each fatty acid were
used including 50 μM, 100 μM and 200 μM. 0.1 % etha-
nol was used as a vehicle control. Additional assays were
performed to observe the effects of various EPA concen-
trations (100 μM, 120 μM, 140 μM, 160 μM, 180 μM
and 200 μM) on cell proliferation of HCT-15 cells after
48 h of treatment. The treatment concentrations of free
fatty acid extract of oils (krill oil or fish oil) are 0.03,
0.06, 0.12 or 0.24 μL/100 μL well. 1 % DMSO was used
as a vehicle control. Non -treated cells were used as a
negative control in all experiments. 10 μL WST-1 re-
agent was added to each well after respective treatment
time points and incubated at 37 °C for one hour. Cell
proliferation was measured using a microplate reader
(Varioskan Flash, Thermo Scientific) at the absorbance
of 450 nm.
Apoptosis assay
Cells (1 × 103 cells/well) were grown in 96-well plates
with a clear flat bottom (Corning™ Costar™ 3603, USA)
at 37 °C for 24 h. They were then treated by EPA at
100 μM or 200 μM, free fatty acid extract from krill oil
at 0.12 μL/100 μM well for 48 h. After removing the
media, cells were washed twice by using PBS. Apoptosis/
Necrosis was detected using the commercial kit
(ab176749, Abcam, Cambridge, England). Cells were ex-
amined under the fluorescence microscope (Olympus
1 × 81). The apoptosis was determined by comparing the
number of treated cells against the control. Each
experiment was performed in quadruplicates, and it was
carried out three times for each cell line.
Mitochondrial membrane potential JC-10 assay
Cells were seeded at 20 × 104 cells/well in the clear bot-
tom 96-well plates (Corning™ Costar™ 3603, USA) to in-
cubate for 24 h at 37 °C. Then the media was added
with EPA at 100 μM or 200 μM, or free fatty acid ex-
tract from krill oil at 0.12 μL/100 μL well and incu-
bated for 48 h. The mitochondrial membrane potential
was measured by using the JC-10 mitochondrial mem-
brane potential assay kit (ab 112134) as per the manu-
facturer’s instructions (Abcam). In brief, 50 μL of JC-10
reagents was added to each well after the treatment,
and incubated for one hour at 37 °C in dark. 50 μL of
assay buffer was added to each well. Fluorescence intensity
was measured using a microplate reader (Varioskan Flash,
Thermo Scientific) at Ex/Em = 485/520 nm and Ex/Em=
540/570 nm. The mitochondrial membrane potential
changes were measured as the ratio between aggregate
(Em 520 nm) and monomeric forms (Em 570 nm) of JC-
10. The increases of the ratio indicate the mitochondrial
membrane depolarisation. Quadruplicates were performed
for each treatment and two individual experiments were
conducted for each cell line.
Analysis of fatty acid composition in EPA treated cancer
cells
HCT-15 cells were seeded at a density of 5 × 105 cells/
well in 6-well plates and incubated for 24 h at 37 °C.
EPA (100 μM or 200 μM) was added to each well. Each
treatment was performed in triplicate. After 48 h incuba-
tion, cells were collected into 15 ml Falcon tubes and
centrifuged at 1300 rpm for 6 min (Thermo Scientific
Haraeus, Megafuge 40). The cell pellets were then used
to extract fatty acid methyl esters (FAME) using a modi-
fied transesterification method of Lepage and Roy [29].
Briefly, cell pellets were mixed with 2 mL of internal
standard, heneicosanoic acid, C21:0 (180 μg) (Nu-Chek
Prep, Inc., Elysian, MN) in methanol:toluene (4:1 (v/v)).
200 μL of acetyl chloride was then added and the mix-
ture was incubated for 1 h at 100 °C to form FAME.
5 mL of 6 % potassium carbonate (K2CO3) in distilled
water was then added and the blend was thoroughly vor-
texed prior to centrifugation at 3000 × g (Sigma 3–30 K)
for 10 min to separate the layers. The top toluene-rich
layer was removed and evaporated to dryness under ni-
trogen. 200 μL of petroleum ether was added and the
resulting FAME was separated by the Gas Chromatog-
raphy (GC). The GC (Varian Star 3400Cx, Agilent Tech-
nologies, CA, USA) was equipped with a SGE BPX 70
capillary column (60 m × 0.25 mm internal diameter,
0.25 μm film thickness) (SGE Analytical Science,
Melbourne, Australia), and a flame ionization detector
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(FID). For each sample, 2 μL was injected in splitting
mode (1:10) with helium as the carrier gas. Fatty acids
were identified by comparison with a standard FAME
mixture, GLC reference standard 403 (Nu-Chek Prep,
Inc., Elysian, MN). The composition of each fatty acid
was calculated as a percentage of the total amount of
fatty acids in the mixture.
Statistical analysis
All the data were analysed using SPSS 22 software.
Mixed model ANOVA was used to determine the signifi-
cance between treatments. The significance of repeated
measure at different time point was analysed using one
way ANOVA. p < 0.05 was considered significant. The
results were expressed as mean ± SD in Table or mean ±
SEM in Figures.
Results
Effects of PUFA on the proliferation of cancer cells
Human colon cancer cells of HCT-15 and SW-480 cell
lines treated with 200 μM of EPA showed a significant
reduction of cell proliferation at all three time points
(24, 48 and 72 h) compared to cells treated with ethanol
(Fig. 1). It inhibited HCT-15 cell proliferation by 76 ±
0.19 %, 94 ± 0.06 % and 91 ± 0.06 % at 24, 48 and 72 h
respectively (Fig. 1a). For SW-480 cells, the inhibitory ef-
fect was even more remarkable, with 98 ± 0.01 %, 100 ±
0.02 % and 99 ± 0.01 % reduction in cell proliferation be-
ing observed at the three time points respectively
(Fig. 1b). However, treatment with lower EPA concentra-
tion (50 μM and 100 μM) did not show positive results.
Furthermore, no significant effects were recorded after
the treatment with DHA or AA. Caco-2 cells did not re-
spond to the treatment of EPA and other two fatty acids
at any concentrations and any time points.
To investigate the dose dependent effects of EPA on
cell proliferation, four concentrations of EPA solution
ranged from 120 μM to 180 μM in addition to 100 and
200 μM were used to treat HCT-15 cells. As shown in
Fig. 2, a significant reduction of cell growth (p < 0.01)
after 48 h of treatment with 160 μM and 180 μM EPA
was observed. Cell proliferation has been reduced by
60 % and 95 % respectively compared with 97 % reduc-
tion with 200 μM EPA treatment.
Effects of krill oil extract on the proliferation of cancer
cells
HCT-15 cancer cells treated with FFA extracted from
krill oil for 48 h at the concentrations from 0.06 to
0.24 μL/100 μL significantly reduced cell proliferation
compared to DMSO control as shown in Fig. 3a. Simi-
larly, FFA extracted from fish oil also inhibited cell
proliferation but started at the relatively lower con-
centration (0.03 to 0.24 μL/100 μL). The percentage of
cell inhibition by krill oil extract ranged from 94 to
96 %, and by fish oil extract from 90 to 96 %. SW-480
cells responded to treatment with FFA extract of krill
oil and fish oil in the same manner as HCT-15 cells
(results not shown). For Caco-2 cells only the high con-
centration of FFA extract of krill oil (0.24 μL/100 μL)
inhibited cell proliferation significantly (p < 0.01), and this
may be due to the presence of multidrug resistance-
associated proteins in the cells (MRPs) [30]. While lower
concentrations of FFA extract of fish oil (0.06 μL/100 μL
well) exhibited better inhibitory effects.
Effects of krill oil FFA and EPA on apoptosis
As shown in Fig. 4, treatment with EPA at 100 and
200 μM and FFA extract of krill oil at 0.12 μL/100 μL
well for 48 h resulted in a significantly high apoptosis
compared to the control in all three colorectal cancer
cell lines. In addition, cell necrosis increased significantly
after 48 h treatment with 200 μM EPA and 0.12 μL/
100 μL well with FFA extract of krill oil in HCT-15 cells.
For SW-480 cells, necrosis was promoted slightly by
200 μM EPA only (p < 0.01) while none of the treat-
ments affected the cell necrosis in Caco-2 cells.
Effects of krill oil FFA and EPA on MMP of cancer cells
The three cell lines HCT-15, SW-480 and Caco-2 were
treated with EPA at 100 μM and 200 μM, and FFA ex-
tract of krill oil at 0.12 μL/100 μL well for 48 h to meas-
ure the mitochondrial membrane potential (MMP)
change of the cancer cells. Mitochondrial membrane de-
polarisation in all three cell lines was significantly higher
after treatment with FFA extract of krill oil compared to
the control. However, no significant change was ob-
served after EPA treatment (Fig. 5).
PUFA profile of HCT-15 cells after EPA treatment
HCT-15 cells treated with EPA at concentrations of
100 μM and200μM for 48 h resulted in significant in-
creases in EPA incorporation in the cancer cells
(Table 1). EPA treated cells also showed a significantly
lower level of AA, especially in cells treated with
200 μM EPA. In addition, 100 μM EPA treatment re-
sulted in a significant increase in DPA (22:5 n-3) level in
the cells. Consistently a higher n-3/n-6 ratio was ob-
served in EPA treated cells at both concentrations.
Discussion
The main objective of the current study was to investi-
gate the effect of krill oil extract on three human CRC
cell lines, HCT-15, SW-480 and Caco-2 cells. The study
has demonstrated that FFA extract of krill oil can inhibit
cell proliferation significantly in HCT-15 and SW-480
cells, and induced cell apoptosis in all three cell lines.
The anti-proliferative effect of krill oil is consistent with
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the previous studies on colorectal cancer and osteosar-
coma cells [8, 26]. Su and co-authors [8] found that the
anti-proliferative role of krill oil on osteosarcoma is
comparable with 500nM of doxorubicine, a commonly
used clinical drug for cancer treatment [31]. The positive
outcomes from this study suggest that krill oil may po-
tentially be a useful cancer therapy tool, especially since
no adverse effects have been reported with krill oil con-
sumption [23]. Further animal studies are required to
confirm the anti-cancer effects of krill oil on CRC in
vivo.
It appears likely that the anti-proliferative and pro-
apoptotic effects of krill oil extract may be attributed to
the EPA in this marine oil. A number of studies have
reported the inhibitory effects of EPA, DHA and fish
oil on the growth and development of various cancers
in vitro and in vivo [6, 13, 32–35]. In vitro studies
showed that treatment with EPA or DHA resulted in
growth arrest in various human cancer cells. Various
mechanisms underlying the anti-cancer effects of EPA
have been proposed. These include the inhibition of
production of prostaglandin E2 (PGE2) [36], an
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Fig. 1 Proliferation of cancer cells after treatment with PUFA. ** indicates a significant difference (p < 0.01) compared with ethanol. a HCT-15 cell
line; b SW-480 cell line
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eicosanoid derived from the AA, which is associated
with cell proliferation, differentiation, apoptosis, angio-
genesis and metastasis [37, 38]. EPA competes with AA
for the metabolic pathway as they are both catalysed by
the same enzymes, and therefore when a high level of
EPA is in the cells, more eicosanoids derived from EPA
(PGE3) will be produced. These eicosanoids inhibit the
activity of Akt/pkB kinase expression that reduces the
PGE2 level [5] and have contrasting properties to PGE2,
such as anti-inflammatory, anti-proliferation and pro-
apoptosis [19, 39].
In addition, EPA treatment has been found to induce
cell apoptosis via arresting cell cycle in pancreatic cancer
cells [40]. This reduced the level of anti-apoptotic bcl-2
protein expression in human leukaemia cells [41]. Chi et
al. have shown that EPA induced cell apoptosis activa-
tion via p53 dependent Fas/FasL pathway in hepatoma
cells [42]. The role of EPA in the modulation of gene ex-
pression and activation of caspases involved in cancer
cell apoptosis has also been reported [43, 44]. Further-
more, Fukui et al. have shown both in vitro and in vivo
that the anti-cancer effects of EPA is associated with the
cell death resulted from the accumulation of ROS in the
cancer cells [17].
Studies have also shown that EPA and DHA induced
apoptosis of colon cancer cells through mitochondrial
pathway involving a change of mitochondrial mem-
brane potential (MMP), and the release of cytochrome
c and other pro-apoptotic factors leading to cell death.
In addition, it has been reported that EPA treatment in
vitro [17, 45, 46] and FO supplementation in vivo [47,
48] could increase ROS and Ca2+ levels in
mitochondria and disrupt mitochondrial membrane
potential leading to cell apoptosis in various human
and rat cancer cells. To investigate whether the pro-
apoptotic effect of EPA and krill oil extract in the
present study was through mitochondrial pathway, we
evaluated the changes in MMP after 48 h of treatment.
It was found that there was a significant increase in the
depolarization of mitochondria membrane in the cells
treated with krill oil extract, and this was correlated
with the number of apoptotic cells in the three cell
lines (Figs. 4 & 5). However treatment with EPA or
DHA did not show significant effect on MMP as krill
oil extract (Fig. 5, data on DHA not shown). The re-
sults from the current study on MMP suggest that
other components of the krill oil extract may play a
role in the alteration of MMP, and the EPA induced cell
apoptosis was possibly through other mechanisms ra-
ther than mitochondrial pathway. Further studies are
required to fully understand the mechanisms under-
lying the pro-apoptotic effects of krill oil extract and
whether other mechanistic pathways such as changes in
cell cycle, signalling receptors, intracellular Ca2+ bal-
ance, and induced stress in endoplasmic reticulum etc.
also play a role [49].
Studies have shown the anti-cancer effect of DHA
on several cancer cell types including colorectal cells
[13, 50, 51]. DHA was found to reduce cell prolifera-
tion more efficiently than EPA by Schonberg et al.
[52]. In the current study, we have not found signifi-
cant cell inhibition by DHA at concentrations between
50 μM to 200 μM in any of the three cancer cell lines.
Our results are at discrepancy with the previous report
on SW-480 and Caco-2 cells that showed significant
inhibition on cell growth after DHA treatment [53].
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Fig. 2 Proliferation of HCT-15 cells after 48 h of treatment with EPA. ** indicates a significant difference (p < 0.01) compared with ethanol
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Corsetto et al. have reported that DHA inhibits cell
growth at the concentrations higher than 200 μM [37].
Schonberg et al. Schonberg SA et al. have found that
SW-480 cells are more resistant to DHA treatment
[52]. Further study is required to investigate whether
higher concentration of DHA can exert anti-cancer ef-
fects on HCT-15, SW-408 and Caco-2 cells.
Lipid synthesis is one of the critical functions in cell
growth and proliferation. Previous studies have shown
that n-3 PUFA induced cell apoptosis is mainly via
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Fig. 3 Proliferation of human colon cancer cells after 48 h of treatment with FFA extracts of krill oil and fish oil. ** indicates a significant
difference (p < 0.01) compared with DMSO control. a HCT-15 cells; b Caco-2 cells
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asymmetric lipid disruption in the cell membrane lead-
ing to changes in cell membrane structure, signal path-
ways and control intracellular homeostasis [54–56]. The
results of this study have shown that higher concentra-
tion of EPA (200 μM) effectively reduced the cell prolif-
eration in HCT-15 and SW-480 cells. It also highlighted
a significant increase in cellular EPA and n-3 fatty acid
levels in the cells treated by EPA, and a significant re-
duction of AA level after treatment with EPA. Consist-
ently, other studies have also shown that EPA
supplementation could significantly increase EPA level
in the cells, and that suppressed cell proliferation and
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Fig. 4 Apoptosis of human colon cancer cells after 48 h of treatment with EPA and FFA extract of krill oil. ** indicates a significant difference
(p < 0.01) compared with the control. a HCT-15 cells; b SW480 cells; c Caco-2 cells
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induced apoptosis [36, 57]. In addition, EPA treatment
has significantly increased docosapentaenoic acid (DPA
n-3) at the present study. This is in agreement with the
results reported by Calviello [57]. This indicates that
EPA, after incorporation into cells, maybe further meta-
bolised through elongation to DPA [8]. DPA is also a
long chain n-3 PUFA but its health benefits on cancer
and other diseases are limited in comparison with EPA
and DHA [58].
The results of this study have shown a significant in-
crease in n-3/n-6 ratio after treatment with EPA at both
100 and 200 μM. This is consistent with other studies
[59], and it may have clinical relevance. The significantly
higher n-3/n-6 ratio has been reported to be associated
with a ranged of health benefits including attenuation of
carcinogenesis [58]. Mansara et al. also found that a low
n-6/n-3 ratio was associated with a decrease in cancer
cell proliferation [59].
Our study has demonstrated that the FFA extract of
krill oil showed similar anti-proliferative effects as that
from fish oil except a slightly more krill oil extract is re-
quired to achieve the similar outcomes (Fig. 3). This
may be attributed to the higher concentration of EPA in
the fish oil. Animal studies are required to compare the
anti-cancer effects of krill oil with fish oil given that
studies have suggested that krill oil has a higher bioavail-
ability than fish oil due to the unique chemical compos-
ition and thus the higher efficiency of fatty acid
absorption into the blood [60].
This is the first study to report the pro-apoptotic ef-
fects of krill oil on human CRC cells. Although the
mechanism is not clear, mitochondrial pathway seems to
play a role. It is not known how EPA induced apoptosis
at the present study. Krill oil contains a range of FFA in-
cluding saturated fatty acids (SFA), monounsaturated
fatty acids (MUFA) and polyunsaturated fatty acids
(PUFA). It could be the synergistic effects of EPA with
other fatty acids that resulted in the change of MMP.
Taken together, these findings suggest that the pro-
apoptotic properties of the krill oil extract may be
associated with a complex mechanism, which requires
further investigation on the interactions between the in-
dividual fatty acids in the oil and evaluation of molecular
biomarkers involved in both the intrinsic and extrinsic
pathways.
Conclusion
Krill oil extract has a pro-apoptotic effect on the human
CRC cells HCT-15, SW-480 and Caco-2. Its anti-
proliferative role was also observed in HCT-15 and SW-
480 cells. EPA treatment showed similar health benefits
Table 1 Fatty acid composition of HCT cells treated by different
EPA concentrations
Control Ethanol EPA (100 μM) EPA (200 μM)
LA (n-6) 0.62 ± 0.04a 0.59 ± 0.01a 0.47 ± 0.02b 0.44 ± 0.01b
ALA (n-3) 0.10 ± 0.02 0.09 ± 0.01 0.08 ± 0.01 0.09 ± 0.00
AA (20:4 n-6) 1.46 ± 0.12a 1.44 ± 0.06a 0.89 ± 0.02b 0.74 ± 0.06b
EPA (20:5 n-3) 0.25 ± 0.03a 0.27 ± 0.05a 5.97 ± 0.11b 9.57 ± 0.64c
DPA (22:5 n-3) 0.71 ± 0.03a 0.72 ± 0.01a 2.75 ± 0.05b 1.54 ± 0.12b
DHA (22:6 n-3) 0.76 ± 0.03a 0.71 ± 0.02a 0.37 ± 0.01b 0.36 ± 0.01b
EPA + DHA 1.00 ± 0.05a 0.98 ± 0.03a 6.33 ± 0.11b 9.92 ± 0.63c
Total n-3 1.81 ± 0.09a 1.79 ± 0.04a 9.16 ± 0.16b 11.55 ± 0.76b
Total n-6 2.07 ± 0.14a 2.03 ± 0.06a 1.36 ± 0.03b 1.17 ± 0.06b
n3/n6 0.87 ± 0.25a 0.88 ± 0.01a 6.72 ± 0.11b 9.85 ± 0.69c
Values expressed as mean ± SD. Values in the same row with different
superscript letters indicate the significance (p < 0.05)
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Fig. 5 Change in mitochondrial membrane potential (MMP) after
treatment with EPA and FFA extract of krill oil for 48 h. ** indicates a
significant difference (p < 0.01) compared with the control. a HCT-15
cells; b SW480 cells; c Caco-2 cells
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as the FFA extract of krill oil. The FFA extract of krill oil
induced the apoptosis of cancer cells may involve a
mitochondria-mediated pathway. However, the apoptosis
resulted from EPA treatment appears to be independent
of the mitochondrial pathway. Further study is required
to elucidate the complex mechanisms underlying the
anti-cancer properties of krill oil extract. The outcomes
of this study showed that krill oil may be protective
against CRC as daily nutrient or as a conjunctive therapy
for the CRC treatment.
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